Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000912282-26-001403·PharmAla Biotech Holdings Inc.
Schedule 13G ownership disclosure
JUPITER NEUROSCIENCES INC
Common Stock, par value $0.0001 per share · CUSIP: 48208B203
Event date: 2026-09-30
- Filing-level shares
- 132,867
- Percent of class
- 10.1%
- PharmAla Biotech Holdings Inc.
Shares: 132,867 · Class: 10.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000912282-26-001403
- Form type
- SCHEDULE 13G/A
- Filer
- PharmAla Biotech Holdings Inc.
- CIK
- CIK 2155983
- Filed
- Oct 26, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership